FdaApplication
NDA 220605
Identifiers
- fda_app_no: NDA220605
Properties
| Property | Value |
|---|---|
| applicant_name | TAKEDA PHARMS AM |
| application_type | NDA |
| approval_date | 2026-08-28 |
Products (5)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MIMRYLO | RUSFERTIDE ACETATE | EQ 28MG BASE/VIAL | POWDER;SUBCUTANEOUS |
| MIMRYLO | RUSFERTIDE ACETATE | EQ 41MG BASE/VIAL | POWDER;SUBCUTANEOUS |
| MIMRYLO | RUSFERTIDE ACETATE | EQ 19MG BASE/VIAL | POWDER;SUBCUTANEOUS |
| MIMRYLO | RUSFERTIDE ACETATE | EQ 54MG BASE/VIAL | POWDER;SUBCUTANEOUS |
| MIMRYLO | RUSFERTIDE ACETATE | EQ 9.5MG BASE/VIAL | POWDER;SUBCUTANEOUS |
5 products